Company
VeraDermics
Description
Veradermics announced the closing of a $75 million Series B financing, led by Suvretta Capital Management and Longitude Capital. The financing will be used to fund the ongoing pivotal clinical development of Veradermics’ lead candidate VDPHL01 for the treatment of androgenetic alopecia (AGA) or pattern hair loss (PHL).
Quick answer
Veradermics Names Reid Waldman as Chief Executive Officer (December 11, 2024). VeraDermics is based in West Hartford, Connecticut, United States.
- What did VeraDermics announce on December 11, 2024?
- Veradermics announced the closing of a $75 million Series B financing, led by Suvretta Capital Management and Longitude Capital. The financing will be used to fund the ongoing pivotal clinical development of Veradermics’ lead candidate VDPHL01 for the treatment of androgenetic alopecia (AGA) or pattern hair loss (PHL).
- What does VeraDermics do?
- Veradermics is a dermatologist-founded, late clinical-stage biopharmaceutical company focused on turning everyday dermatology and aesthetics problems into clear, proven care.
- Where is VeraDermics based?
- VeraDermics is based in West Hartford, Connecticut, United States.
- Which similar companies made leadership changes around the same time?
- Rockwell Medical (December 12, 2024), Beam Therapeutics Inc. (December 6, 2024), TeleMed2U (December 16, 2024) and Zomedica (December 19, 2024) also announced leadership changes within 45 days of VeraDermics.
Source: Fundz verified event record.
Other recent leadership changes in Healthcare and Health Care
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Rockwell Medical, Inc. Promotes Jesse Neri to Chief Financial Officer (December 12, 2024)
- Beam Therapeutics Inc. Appoints Sravan K. Emany as Chief Financial Officer (December 6, 2024)
- TeleMed2U Appoints Rachel Rhodes, D.O. as National Director of Behavioral Health Services (December 16, 2024)
- Zomedica Appoints Scott A. Jordan as Executive Vice President, Finance & Chief Financial Officer (December 19, 2024)
- GenomOncology Appoints Dr. Jonathan 'Jack' Lord, M.D. as Chief Innovation Officer and Chief Operating Officer (December 19, 2024)
- Guy Guglielmino Joins Treace Medical Concepts, Inc. as Chief Commercial Officer (December 2, 2024)
Who to call at VeraDermics, and when
A new leader at VeraDermics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day VeraDermics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at VeraDermics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at VeraDermics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment VeraDermics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
VeraDermics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.